This inventor holds 22 USPTO granted patents, plus 1 CIPO patent, primarily in Antibiotic Development. Top assignees: Eli Lilly and Company, Dowelanco. Active years: 1978-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Indianapolis, IN (US) (1978 - 1998)
- Seattle, WA (US) (1997 - 1998)
Company Filing History:
Years Active: 1978-1998
Areas of Expertise:
Title: The Innovative Contributions of Walter M. Nakatsukasa
Introduction
Walter M. Nakatsukasa is a prominent inventor located in Indianapolis, Indiana, renowned for his significant contributions to the field of pharmaceuticals and agriculture. With an impressive portfolio of 22 patents, Nakatsukasa has made substantial advancements through his research and innovations, particularly in the development of antibiotics and insect control substances.
Latest Patents
Among his latest inventions are:
1. **A82846 antibiotics** - This new glycopeptide antibiotic, comprising A82846A, A82846B, and A82846C, is produced by Nocardia orientalis strains NRRL 18098, NRRL 18099, and NRRL 18100. The A82846 antibiotics demonstrate activity against Gram-positive bacteria that is comparable to vancomycin, marking a significant advancement in antibiotic development.
2. **A83543 compounds and process for production thereof** - This patent involves new A83543 components, including various fermentation products such as A83543K, A835430, A83543P, A83543U, A83543V, A83543W, and A83543Y, along with their N-demethyl derivatives and salts. These compounds are instrumental in controlling insects and mites, with methods provided for their preparation through the culturing of multiple strains of Saccharopolyspora spinosa, including NRRL 18395 and NRRL 18537.
Career Highlights
Walter M. Nakatsukasa has held pivotal roles in prestigious companies, including Eli Lilly and Company and Dow AgroSciences, where he applied his innovative thinking to solve complex challenges in pharmaceutical developments and agricultural solutions. His extensive experience in these organizations has contributed greatly to his depth of knowledge and success as an inventor.
Collaborations
Throughout his career, Nakatsukasa has collaborated with noteworthy colleagues, including James A. Mabe and Robert L. Hamill. These collaborations have further enriched his research and innovations, leading to advancements that benefit public health and agriculture.
Conclusion
Walter M. Nakatsukasa exemplifies the spirit of innovation through his numerous patents and collaborations. His work continues to impact the fields of medicine and agricultural science, and as he builds upon his already impressive portfolio, the future of his contributions looks promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile